Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis | Zendy

J. Beyer | Zendy; G. Barzen | Zendy; G. RISSE | Zendy; C. Weyer | Zendy; Klaus Miksits | Zendy; K. Dullenkopf | Zendy; D. Huhn | Zendy; W. Siegert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis

Author(s) -

J. Beyer,

G. Barzen,

G. RISSE,

C. Weyer,

Klaus Miksits,

K. Dullenkopf,

D. Huhn,

W. Siegert

Publication year - 1993

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.37.6.1367

Subject(s) - amphotericin b , aspergillosis , pharmacokinetics , aerosol , medicine , drug , pharmacology , absorption (acoustics) , immunology , chemistry , dermatology , antifungal , materials science , organic chemistry , composite material

The pharmacokinetics and applicability of aerosol amphotericin B administrations were studied in 40 neutropenic patients and 4 healthy volunteers. Particle size was measured and pulmonary deposition was demonstrated by radioisotope studies. Inhalations were easy to administer and were well tolerated, with minimal systemic absorption of the drug.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research